NCT04672499View on ClinicalTrials.gov

Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

September 7, 2020

Study Completion Date

September 7, 2020

Conditions
Healthy
Interventions
DRUG

Miricorilant 300 mg tablets

Miricorilant 300 mg tablets for oral administration

DRUG

Miricorilant 150 mg tablets

Miricorilant 150 mg tablets for oral administration

DRUG

Placebo 150 mg tablets

Placebo to match miricorilant 150 mg tablets for oral administration

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY